⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3717073 | 1.00 | — | — | |
| SCHEMBL6903897 | 0.93 | — | — | |
| SCHEMBL15594561 | 0.93 | — | — | |
| SCHEMBL8535020 | 0.82 | — | — | |
| SCHEMBL5429454 | 0.80 | CYP2D6 (0.39) | — | |
| SCHEMBL6416529 | 0.77 | — | — | |
| Tert-Butyl Formate SCHEMBL27822453 | 0.77 | TDP1 (0.41) | — | |
| SCHEMBL7155220 | 0.76 | — | — | |
| SCHEMBL7158350 | 0.76 | — | — | |
| SCHEMBL1479655 | 0.76 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116134035-A | 3- (1H-imidazol-2-yl) -2,3,8 a-tetrahydroindol-5 (1H) -one derivatives useful as factor XIA inhibitors | 詹森药业有限公司 | 2023-05-16 | — | — | CN | disclosed |
| US-10544146-B2 | Bicyclic compounds and their use as antibacterial agents and β-lactamase inhibitors | FEDORA PHARMACEUTICALS INC. (CA) | 2020-01-28 | — | — | US | disclosed |
| US-10030019-B2 | Bicyclic compounds and their use as antibacterial agents and β-lactamase inhibitors | FEDORA PHARMACEUTICALS INC. (CA) | 2018-07-24 | — | — | US | disclosed |
| US-9771375-B2 | Indazole compounds useful as ketohexokinase inhibitors | JANSSEN PHARMACEUTICA NV (BE) | 2017-09-26 | — | — | US | disclosed |
| EP-2373679-B1 | MINI-HEPCIDIN PEPTIDES AND METHODS OF USING THEREOF | UNIV CALIFORNIA (US) | 2017-03-08 | — | — | EP | disclosed |
| US-20140336170-A1 | INDAZOLE COMPOUNDS USEFUL AS KETOHEXOKINASE INHIBITORS | JANSSEN PHARMACEUTICA NV (US) | 2014-11-13 | — | — | US | disclosed |
| CN-102427726-B | fused ring inhibitors of hepatitis c | PRESIDIO PHARMACEUTICALS, INC. (US) | 2014-10-08 | — | — | CN | disclosed |
| US-8822447-B2 | Indazole compounds useful as ketohexokinase inhibitors | JANSSEN PHARMACEUTICA NV (BE) | 2014-09-02 | — | — | US | disclosed |
| US-20110263559-A1 | INDAZOLE COMPOUNDS USEFUL AS KETOHEXOKINASE INHIBITORS | JANSSEN PHARMACEUTICA N.V. (BE) | 2011-10-27 | — | — | US | disclosed |
| EP-1720855-A4 | INHIBITORS OF AKT ACTIVITY | SMITHKLINE BEECHAM CORP (US) | 2008-12-17 | — | — | EP | disclosed |
| EP-1720855-A1 | INHIBITORS OF AKT ACTIVITY | SMITHKLINE BEECHAM CORPORATION (US) | 2006-11-15 | — | — | EP | disclosed |
| WO-2005085227-A1 | INHIBITORS OF AKT ACTIVITY | SMITHKLINE BEECHAM CORPORATION (US) | 2005-09-15 | — | — | WO | disclosed |
| CN-1166489-A | Prep. of novel alkyl-substituted alpha-ketone ester | AMERICAN CYANAMID CO (US) | 1997-12-03 | — | — | CN | disclosed |
| CN-1065061-A | Novel 4-substituted azetidinones as precursors to 2-substituted-3-carboxycarbapenem antibiotics and processes for their preparation | AMERICAN CYANAMID CO (US) | 1992-10-07 | — | — | CN | disclosed |
| US-4198424-A | ANALGESICS | BYK GULDEN LOMBERG CHEMISCHE FABRIK GMBH (DE) | 1980-04-15 | — | — | US | disclosed |